Crossmark

Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis

Crossref DOI link: https://doi.org/10.1007/s10875-023-01451-5

Published Online: 2023-02-23

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Arango-Franco, Carlos A.

Migaud, Mélanie

Ramírez-Sánchez, Isabel Cristina

Arango-Bustamante, Karen

Moncada-Vélez, Marcela

Rojas, Julián

Gervais, Adrian

Patiño-Giraldo, Santiago

Perez-Zapata, Lizeth J.

Álvarez Álvarez, Jesús A.

Orrego, Julio César

Roncancio-Villamil, Gustavo

Boisson-Dupuis, Stéphanie

Jouanguy, Emmanuelle

Abel, Laurent

Casanova, Jean-Laurent

Bustamante, Jacinta

Arias, Andrés A.

Franco, José Luis

Puel, Anne https://orcid.org/0000-0003-2603-0323
Funding

Funding for this research was provided by:

Departamento Administrativo de Ciencia, Tecnología e Innovación (111574455633, Contract number 544-2016)

ECOS-NORD (grant #63407-2018-C19S01-63407)

Comité para el desarrollo de la investigación CODI UdeA (2017-16003, 111584467551. CT 415-2020)

ESID European Society for Immunodeficiencies (ESID midterm fellowship)

Fundación “Diana-García de Olarte” para las Inmunodeficiencias Primarias (FIP (FIP autoantibodies Medellin Colombia)

National Institutes of Health (R01AI127564)

NIH Clinical and Translational Science Award (UL1TR001866)

French National Research Agency (ANR-10-IAHU-01)

Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID)

Cross Lab Imagine Grant (WP05T051)

French Foundation for Medical Research (EQU201903007798)
License Information

Text and Data Mining valid from 2023-02-23

Version of Record valid from 2023-02-23
More Information

Article History

Received: 3 August 2022

Accepted: 9 February 2023

First Online: 23 February 2023

Declarations

:

: Informed consent for participation in this study was obtained in accordance with local regulations, with approval from the IRB. The experiments described here were performed in Colombia and in France, in accordance with local regulations, and with the approval of the IRB of Necker Hospital for Sick Children, France and the local review board of the Universidad de Antioquia (F8790-07–0010).

: Written informed consent to participate was obtained from all the patients.

: Consent to publish this report was obtained from patients. All the authors approved the final version of the manuscript.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below